1. Changes in the Evaluation and Management of Adrenocortical Carcinoma

   • Barbra S. Miller

   Endocrine Tumors 17 September 2018 Pages: 3413 - 3415

2. Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed

   • Jamie Green Rand
   • Mark B. Faries

   Melanoma 12 September 2018 Pages: 3416 - 3418

3. Dynamic Behavior of Ca 19-9 and Pancreatic Cancer Recurrence: Enough Data to Drive Salvage Therapy?

   • Giuseppe Malleo

   Pancreatic Tumors 20 August 2018 Pages: 3419 - 3420

4. Declining Use of Orthotopic Reconstruction for Bladder Cancer

   • Richard Hautmann
   • Christian Bolenz

   Urologic Oncology 18 July 2018 Pages: 3421 - 3422

5. Patient Selection for Active Surveillance in the Multi-parametric Magnetic Resonance Imaging Era: A Step Forward in a Rapidly Evolving Field

   • Matteo Ferro
   • Vincenzo Mirone
   • Massimiliano Creta

   Urologic Oncology 10 September 2018 Pages: 3423 - 3424

6. Beyond TNM: Searching for New Patient-Centric Prognostic Indicators in NSCLC

   • Areo G. Saffarzadeh
   • Justin D. Blasberg

   Thoracic Oncology 28 August 2018 Pages: 3425 - 3426

7. Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study

   • Samer Tohme
   • Christof Kaltenmeier
   • Allan Tsung

   Health Services Research and Global Oncology 24 July 2018 Pages: 3427 - 3435

   

8. An Examination of Applicants and Factors Associated with Matriculation to Complex General Surgical Oncology Fellowship Training Programs

   • Michael M. Wach
   • Samantha M. Ruff
   • Jonathan M. Hernandez

   Health Services Research and Global Oncology 27 July 2018 Pages: 3436 - 3442

   

9. ASO Author Reflections: Perspectives on the Application Process to Complex General Surgical Oncology Fellowship Training

   • Jonathan M. Hernandez

   ASO Author Reflections 23 August 2018 Pages: 3443 - 3444

10. Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship

    • L. Mark Knab
    • Mazen S. Zenati
    • Melissa E. Hogg

    Health Services Research and Global Oncology 02 August 2018 Pages: 3445 - 3452

    

11. Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

    • Paxton V. Dickson
    • Lawrence Kim
    • Carmen C. Solórzano

    Endocrine Tumors 14 September 2018 Pages: 3453 - 3459

12. Evaluation, Staging, and Surgical Management for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

    • Paxton V. Dickson
    • Lawrence Kim
    • Carmen C. Solórzano

    Endocrine Tumors 18 September 2018 Pages: 3460 - 3468

    

13. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma

    • Andrew J. Sinnamon
    • Yun Song
    • Giorgos C. Karakousis

    Melanomas 24 July 2018 Pages: 3469 - 3475

    

14. Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities

    • Hidde M. Kroon
    • Wendy D. van der Bol
    • John F. Thompson

    Melanoma 16 August 2018 Pages: 3476 - 3482

    

15. CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time

    • Caroline J. Rieser
    • Mazen Zenati
    • Melissa E. Hogg

    Pancreatic Tumors 21 May 2018 Pages: 3483 - 3491

    

16. Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium

    • J. V. Groen
    • B. G. Sibinga Mulder
    • J. S. D. Mieog

    Pancreatic Tumors Open access 27 August 2018 Pages: 3492 - 3501

    

17. Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014

    • Christer Groeben
    • Rainer Koch
    • Johannes Huber

    Urologic Oncology 21 February 2018 Pages: 3502 - 3509

    

18. Contemporary Epstein Criteria with Biopsy-Naïve Multiparametric Magnetic Resonance Imaging to Prevent Incorrect Assignment to Active Surveillance in the PI-RADS Version 2.0 Era

    • Yu Fan
    • Lingyun Zhai
    • Jie Jin

    Urologic Oncology 17 September 2018 Pages: 3510 - 3517

    

19. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling

    • Chun-Te Wu
    • Wei-Yu Lin
    • Miao-Fen Chen

    Urologic Oncology 20 August 2018 Pages: 3518 - 3526

    

20. Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series

    • Samantha Grossmith
    • Anvy Nguyen
    • Tari A. King

    Breast Oncology 04 June 2018 Pages: 3527 - 3534

    

21. Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How?

    • Lucy M. De La Cruz
    • Michael O. Harhay
    • Stacy Ugras

    Breast Oncology 06 July 2018 Pages: 3535 - 3540

    

22. Margins in Breast-Conserving Surgery After Neoadjuvant Therapy

    • Jungeun Choi
    • Alison Laws
    • Tari King

    Breast Oncology 20 August 2018 Pages: 3541 - 3547

    

23. Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy

    • Alison Laws
    • Kathryn Anderson
    • Tari A. King

    Breast Oncology 20 August 2018 Pages: 3548 - 3555

    

24. Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis

    • Kristin A. Theobald
    • Lisa R. Susswein
    • Benjamin D. Solomon

    Breast Oncology 30 August 2018 Pages: 3556 - 3562

    

25. Patient-Reported Outcome Measures May Add Value in Breast Cancer Surgery

    • M. Lagendijk
    • L. S. E. van Egdom
    • L. B. Koppert

    Breast Oncology Open access 03 September 2018 Pages: 3563 - 3571

    

26. Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives

    • Philippe Rouanet
    • Martin Marie Bertrand
    • Pierre-Emmanuel Colombo

    Colorectal Cancer 31 August 2018 Pages: 3572 - 3579

    

27. Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients

    • Giuseppe Spinoglio
    • Paolo P. Bianchi
    • Emilio Bertani

    Colorectal Cancer 14 September 2018 Pages: 3580 - 3586

    

28. Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach?

    • Robert K. Cleary
    • Arden M. Morris
    • Amy L. Halverson

    Colorectal Cancer 05 September 2018 Pages: 3587 - 3595

    

29. Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer

    • Tatsuto Nishigori
    • Shigeru Tsunoda
    • Yoshiharu Sakai

    Gastrointestinal Oncology 30 August 2018 Pages: 3596 - 3603

    

30. Surgical Outcomes of Reduced-Port Laparoscopic Gastrectomy Versus Conventional Laparoscopic Gastrectomy for Gastric Cancer: A Propensity-Matched Retrospective Cohort Study

    • Chikara Kunisaki
    • Hiroshi Miyamoto
    • Itaru Endo

    Gastrointestinal Oncology 03 September 2018 Pages: 3604 - 3612

    

31. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors

    • David Strosberg
    • Eric B. Schneider
    • Lawrence A. Shirley

    Gastrointestinal Oncology 04 September 2018 Pages: 3613 - 3620

    

32. Factors Associated With Host Immune Response and Number of Lymph Nodes: A Large Retrospective Cohort Study

    • Sun-Ju Byeon
    • You Jeong Heo
    • Tae Sung Sohn

    Gastrointestinal Oncology 04 September 2018 Pages: 3621 - 3628

    

33. Comparison of Outcomes for Elderly Gastric Cancer Patients at Least 80 Years of Age Following Gastrectomy in the United States and China

    • Jian-xian Lin
    • Brendan C. Yi
    • Sam S. Yoon

    Gastrointestinal Oncology 14 September 2018 Pages: 3629 - 3638

    

34. Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies

    • Sha Zhou
    • Shiliang Liu
    • Mian Xi

    Thoracic Oncology 07 September 2018 Pages: 3639 - 3646

    

35. Prognostic Significance of Albumin–Globulin Score in Patients with Operable Non-Small-Cell Lung Cancer

    • Xiang Li
    • Sida Qin
    • Hong Ren

    Thoracic Oncology Open access 18 September 2018 Pages: 3647 - 3659

    

36. Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers

    • Tak Kyu Oh
    • YoungRok Choi
    • Jung-Hee Ryu

    Thoracic Oncology 03 September 2018 Pages: 3660 - 3666

    

37. Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers

    • Tak Kyu Oh
    • Jung-Hee Ryu

    ASO Author Reflections 30 August 2018 Pages: 3667 - 3667

38. Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor

    • Yuta Toyoshima
    • Tomohiko Hara
    • Hiroyuki Fujimoto

    Thoracic Oncology 06 September 2018 Pages: 3668 - 3675

    

39. Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma

    • Koji Matsuo
    • Yutaka Takazawa
    • Lynda D. Roman

    Gynecologic Oncology 13 August 2018 Pages: 3676 - 3684

    

40. Minority Race Predicts Treatment by Non-gynecologic Oncologists in Women with Gynecologic Cancer

    • Amin A. Ramzan
    • Kian Behbakht
    • Saketh R. Guntupalli

    Gynecologic Oncology 13 August 2018 Pages: 3685 - 3691

    

41. Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging

    • Jvan Casarin
    • Francesco Multinu
    • Gretchen Glaser

    Gynecologic Oncology 16 August 2018 Pages: 3692 - 3698

    

42. Frozen Section to Detect Empty Nodes and Improve the Accuracy of the Sentinel Lymph Node Biopsy in Endometrial Cancer

    • Jvan Casarin
    • Gretchen Glaser

    ASO Author Reflections 17 September 2018 Pages: 3699 - 3700

43. BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study

    • Claudia Marchetti
    • Rossella De Leo
    • Anna Fagotti

    Gynecologic Oncology 20 August 2018 Pages: 3701 - 3708

    

44. ASO Author Reflections: BRCA Mutation Status for Personalizing Management of Recurrent Ovarian Cancer—A Multicenter Study

    • Anna Fagotti

    ASO Author Reflections 03 September 2018 Pages: 3709 - 3710

45. Identification of the Thoracic Duct Using Indocyanine Green During Cervical Lymphadenectomy

    • Jeffery Chakedis
    • Lawrence A. Shirley
    • John E. Phay

    Head and Neck Oncology 03 August 2018 Pages: 3711 - 3717

    

46. ASO Author Reflections: Identification of the Thoracic Duct using Indocyanine Green During Cervical Lymphadenectomy

    • Jeffery Chakedis
    • John E. Phay

    ASO Author Reflections 31 August 2018 Pages: 3718 - 3718

47. Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery

    • Simone Conci
    • Andrea Ruzzenente
    • Alfredo Guglielmi

    Hepatobiliary Tumors 07 August 2018 Pages: 3719 - 3727

    

48. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer

    • Yuichiro Okumura
    • Takehiro Noda
    • Masaki Mori

    Translational Research and Biomarkers 13 August 2018 Pages: 3728 - 3737

    

49. ASO Author Reflections: Hypoxia-Induced PLOD2 Is a Key Regulator in Epithelial–Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer

    • Yuichiro Okumura
    • Hidetoshi Eguchi

    ASO Author Reflections 30 August 2018 Pages: 3738 - 3739

50. Doppler Ultrasound-Visible SignalMark Microspheres are Better Identified than HydroMARK^® Clips in a Simulated Intraoperative Setting in Breast and Lung Tissue

    • Rachel K. Voss
    • Erin P. Ward
    • Sarah L. Blair

    Translational Research and Biomarkers 03 September 2018 Pages: 3740 - 3746